RGC
RGC
KYG7487R1002
Regencell Bioscience Holdings L
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2024 2023 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
4.736.726 6.273.671
24.5%
Operating Income -4.736.726 -6.273.671
24.5%
Pretax Income -4.363.221 -6.062.329
28.0%
Net Income Common Stockholders -4.301.837 -5.871.130
26.7%
-- --
--
-- --
--
ende